Justin S Smith1, Christopher I Shaffrey1, Michael P Kelly2, Elizabeth L Yanik2, Jon D Lurie3, Christine R Baldus2, Charles Edwards4, Steven D Glassman5, Lawrence G Lenke6, Oheneba Boachie-Adjei7, Jacob M Buchowski2, Leah Y Carreon5, Charles H Crawford5, Thomas J Errico8, Stephen J Lewis9, Tyler Koski10, Stefan Parent11, Han Jo Kim12, Christopher P Ames13, Shay Bess14, Frank J Schwab12, Keith H Bridwell2. 1. Department of Neurosurgery, University of Virginia, Charlottesville, VA. 2. Department of Orthopedic Surgery, Washington University School of Medicine, St Louis, MO. 3. Department of Medicine, Dartmouth Medical School, Hanover, NH. 4. Mercey Medical Center, Baltimore, MD. 5. Norton Leatherman Spine Center, Louisville, KY. 6. Department of Orthopedic Surgery, Columbia University, New York, NY. 7. FOCOS Orthopedic Hospital, Accra, Ghana. 8. NYU Hospital for Joint Disease, New York, NY. 9. UHN-Orthopedics, Toronto Western Hospital, Toronto, ON. 10. Department of Neurological Surgery, Northwestern University, Chicago, IL. 11. Sainte-Justine University Hospital, Montreal, Quebec, Canada. 12. Hospital for Special Surgery, New York, NY. 13. Department of Neurosurgery, University of California San Francisco, San Francisco, CA. 14. Denver International Spine Center, Presbyterian St. Luke's/Rocky Mountain Hospital for Children, Denver, CO.
Abstract
STUDY DESIGN: Secondary analysis of prospective multicenter cohort. OBJECTIVE: To assess effect of serious adverse events (SAEs) on 2- and 4-year patient-reported outcomes measures (PROMs) in patients surgically treated for adult symptomatic lumbar scoliosis (ASLS). SUMMARY OF BACKGROUND DATA: Operative treatment for ASLS can improve health-related quality of life, but has high rates of SAEs. How these SAEs effect health-related quality of life remain unclear. METHODS: The ASLS study assessed operative versus nonoperative ASLS treatment, with randomized and observational arms. Patients were 40- to 80-years-old with ASLS, defined as lumbar coronal Cobb ≥30° and Oswestry Disability Index (ODI) ≥20 or Scoliosis Research Society-22 (SRS-22) ≤4.0 in pain, function, and/or self-image domains. SRS-22 subscore and ODI were compared between operative patients with and without a related SAE and nonoperative patients using an as-treated analysis combining randomized and observational cohorts. RESULTS: Two hundred eighty-six patients were enrolled, and 2- and 4-year follow-up rates were 90% and 81%, respectively, although at the time of data extraction not all patients were eligible for 4-year follow-up. A total of 97 SAEs were reported among 173 operatively treated patients. The most common were implant failure/pseudarthrosis (n = 25), proximal junctional kyphosis/failure (n = 10), and minor motor deficit (n = 8). At 2 years patients with an SAE improved less than those without an SAE based on SRS-22 (0.52 vs. 0.79, P = 0.004) and ODI (-11.59 vs. -17.34, P = 0.021). These differences were maintained at 4-years for both SRS-22 (0.51 vs. 0.86, P = 0.001) and ODI (-10.73 vs. -16.69, P = 0.012). Despite this effect, patients sustaining an operative SAE had greater PROM improvement than nonoperative patients (P<0.001). CONCLUSION: Patients affected by SAEs following surgery for ASLS had significantly less improvement of PROMs at 2- and 4-year follow-ups versus those without an SAE. Regardless of SAE occurrence, operatively treated patients had significantly greater improvement in PROMs than those treated nonoperatively. LEVEL OF EVIDENCE: 2.
STUDY DESIGN: Secondary analysis of prospective multicenter cohort. OBJECTIVE: To assess effect of serious adverse events (SAEs) on 2- and 4-year patient-reported outcomes measures (PROMs) in patients surgically treated for adult symptomatic lumbar scoliosis (ASLS). SUMMARY OF BACKGROUND DATA: Operative treatment for ASLS can improve health-related quality of life, but has high rates of SAEs. How these SAEs effect health-related quality of life remain unclear. METHODS: The ASLS study assessed operative versus nonoperative ASLS treatment, with randomized and observational arms. Patients were 40- to 80-years-old with ASLS, defined as lumbar coronal Cobb ≥30° and Oswestry Disability Index (ODI) ≥20 or Scoliosis Research Society-22 (SRS-22) ≤4.0 in pain, function, and/or self-image domains. SRS-22 subscore and ODI were compared between operative patients with and without a related SAE and nonoperative patients using an as-treated analysis combining randomized and observational cohorts. RESULTS: Two hundred eighty-six patients were enrolled, and 2- and 4-year follow-up rates were 90% and 81%, respectively, although at the time of data extraction not all patients were eligible for 4-year follow-up. A total of 97 SAEs were reported among 173 operatively treated patients. The most common were implant failure/pseudarthrosis (n = 25), proximal junctional kyphosis/failure (n = 10), and minor motor deficit (n = 8). At 2 years patients with an SAE improved less than those without an SAE based on SRS-22 (0.52 vs. 0.79, P = 0.004) and ODI (-11.59 vs. -17.34, P = 0.021). These differences were maintained at 4-years for both SRS-22 (0.51 vs. 0.86, P = 0.001) and ODI (-10.73 vs. -16.69, P = 0.012). Despite this effect, patients sustaining an operative SAE had greater PROM improvement than nonoperative patients (P<0.001). CONCLUSION: Patients affected by SAEs following surgery for ASLS had significantly less improvement of PROMs at 2- and 4-year follow-ups versus those without an SAE. Regardless of SAE occurrence, operatively treated patients had significantly greater improvement in PROMs than those treated nonoperatively. LEVEL OF EVIDENCE: 2.
Authors: Peter G Passias; Alexandra Soroceanu; Sun Yang; Frank Schwab; Christopher Ames; Anthony Boniello; Justin Smith; Christopher Shaffrey; Oheneba Boachie-Adjei; Gregory Mundis; Douglas Burton; Eric Klineberg; Robert Hart; D Kojo Hamilton; Daniel M Sciubba; Shay Bess; Virginie Lafage Journal: J Bone Joint Surg Am Date: 2016-04-06 Impact factor: 5.284
Authors: Alex Soroceanu; Douglas C Burton; Jonathan Haim Oren; Justin S Smith; Richard Hostin; Christopher I Shaffrey; Behrooz A Akbarnia; Christopher P Ames; Thomas J Errico; Shay Bess; Munish C Gupta; Vedat Deviren; Frank J Schwab; Virginie Lafage Journal: Spine (Phila Pa 1976) Date: 2016-11-15 Impact factor: 3.468
Authors: Justin S Smith; Christopher I Shaffrey; Steven D Glassman; Sigurd H Berven; Frank J Schwab; Christopher L Hamill; William C Horton; Stephen L Ondra; Charles A Sansur; Keith H Bridwell Journal: Spine (Phila Pa 1976) Date: 2011-05-01 Impact factor: 3.468
Authors: Michael M Safaee; Joseph A Osorio; Kushagra Verma; Shay Bess; Christopher I Shaffrey; Justin S Smith; Robert Hart; Vedat Deviren; Christopher P Ames Journal: Oper Neurosurg (Hagerstown) Date: 2017-10-01 Impact factor: 2.703
Authors: Justin S Smith; Christopher I Shaffrey; Shay Bess; Mohammed F Shamji; Darrel Brodke; Lawrence G Lenke; Michael G Fehlings; Virginie Lafage; Frank Schwab; Alexander R Vaccaro; Christopher P Ames Journal: Neurosurgery Date: 2017-03-01 Impact factor: 4.654
Authors: Michael D Daubs; Lawrence G Lenke; Gene Cheh; Georgia Stobbs; Keith H Bridwell Journal: Spine (Phila Pa 1976) Date: 2007-09-15 Impact factor: 3.468
Authors: Justin S Smith; Virginie Lafage; Christopher I Shaffrey; Frank Schwab; Renaud Lafage; Richard Hostin; Michael OʼBrien; Oheneba Boachie-Adjei; Behrooz A Akbarnia; Gregory M Mundis; Thomas Errico; Han Jo Kim; Themistocles S Protopsaltis; D Kojo Hamilton; Justin K Scheer; Daniel Sciubba; Tamir Ailon; Kai-Ming G Fu; Michael P Kelly; Lukas Zebala; Breton Line; Eric Klineberg; Munish Gupta; Vedat Deviren; Robert Hart; Doug Burton; Shay Bess; Christopher P Ames Journal: Neurosurgery Date: 2016-06 Impact factor: 4.654
Authors: Daniel G Kang; Christine Baldus; Steven D Glassman; Christopher I Shaffrey; Jon D Lurie; Keith H Bridwell Journal: Spine (Phila Pa 1976) Date: 2017-04-01 Impact factor: 3.241
Authors: Andrew J Pugely; Michael P Kelly; Christine R Baldus; Yubo Gao; Lukas Zebala; Christopher Shaffrey; Steven Glassman; Oheneba Boachie-Adjei; Stefan Parent; Stephen Lewis; Tyler Koski; Charles Edwards; Frank Schwab; Keith H Bridwell Journal: Spine (Phila Pa 1976) Date: 2018-06-01 Impact factor: 3.241